Kupffer cells modulate hepatic fatty acid oxidation during infection with PR8 influenza  by Tarasenko, Tatyana N. et al.
Biochimica et Biophysica Acta 1852 (2015) 2391–2401
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbad isKupffer cells modulate hepatic fatty acid oxidation during infection with
PR8 inﬂuenzaTatyana N. Tarasenko a, Larry N. Singh b, Milani Chatterji-Len a, Patricia M. Zerfas c,
Kristina Cusmano-Ozog d, Peter J. McGuire a,⁎
a Metabolism, Infection and Immunity Unit, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA
b Center for Mitochondrial and Epigenomic Medicine, Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA, USA
c Ofﬁce of Research Services, Division of Veterinary Resources, National Institutes of Health, Bethesda, MD, USA
d Biochemical Genetics and Metabolism Laboratory, Children's National Medical Center, Washington, DC, USAAbbreviations: PR8, inﬂuenza A/PR/8; IEM, inborn err
acidemia, UCD, urea cycle disorder; pMD, primarymitocho
ture infective dose; MDCK, Madin–Darby canine kidney
non-structural protein; CPT2, carnitine palmitoyl tr
acylcarnitine translocase; Acadvl, very long chain acyl C
chain acyl CoA dehydrogenase; Hadha, hydroxy acyl CoA
transport ﬂavoprotein; Pparα, peroxisome proliferator-a
synthase; Saa, serum amyloid A; Lcn2, lipocalin 2; Irf7, in
I, retinoic acid inducible gene I; MDA-5, melanoma differ
TLR, toll like receptor.
⁎ Corresponding author at: National Human Genom
Institutes of Health, 49 Convent Drive, Room 4A62, Bethe
E-mail address: peter.mcguire@nih.gov (P.J. McGuire)
http://dx.doi.org/10.1016/j.bbadis.2015.08.021
0925-4439/© 2015 Published by Elsevier B.V.a b s t r a c ta r t i c l e i n f oArticle history:
Received 29 May 2015
Received in revised form 20 August 2015
Accepted 25 August 2015
Available online 28 August 2015
Keywords:
β-oxidation
Fatty acids
Metabolism
Innate immune response
InﬂuenzaIn response to infection, patients with inborn errors of metabolism may develop a functional deterioration
termed metabolic decompensation. The biochemical hallmarks of this disruption of metabolic homeostasis are
disease speciﬁc andmay include acidosis, hyperammonemia or hypoglycemia. In amodel systempreviously pub-
lished by our group, we noted that during inﬂuenza infection, mice displayed a depression in hepatic mitochon-
drial enzymes involved in nitrogen metabolism. Based on these ﬁndings, we hypothesized that this normal
adaptation may extend to other metabolic pathways, and as such, may impact various inborn errors of metabo-
lism. Since the liver is a critical organ in inborn errors ofmetabolism,we carried out untargetedmetabolomic pro-
ﬁling of livers using mass spectrometry in C57Bl/6 mice infected with inﬂuenza to characterize metabolic
adaptation. Pathway analysis of metabolomic data revealed reductions in CoA synthesis, and long chain fatty
acyl CoA and carnitine species. These metabolic adaptations coincided with a depression in hepatic long chain
β-oxidation mRNA and protein. To our surprise, the metabolic changes observed occurred in conjunction with
a hepatic innate immune response, as demonstrated by transcriptional proﬁling and ﬂow cytometry. By
employing an immunomodulation strategy to deplete Kupffer cells, we were able to improve the expression of
multiple genes involved in β-oxidation. Based on these ﬁndings, we are the ﬁrst to suggest that the role of the
liver as an immunologic organ is central in the pathophysiology of hepatic metabolic decompensation in inborn
errors of metabolism due to respiratory viral infection.
© 2015 Published by Elsevier B.V.1. Introduction
Although individually rare, the inborn errors of metabolism (IEM)
constitute a medically important class of disorders that are increasingly
recognized through state Newborn Screening programs [1]. Studies of
the metabolic disturbances resulting from these monogenic disordersors of metabolism; OA, organic
ndrial disease; TCID, tissue cul-
epithelial cells; NS1, inﬂuenza
ansferase 2; CACT, carnitine
oA dehydrogenase; Acadl, long
dehydrogenase; Etfa, electron
ctivated alpha; Fasn, fatty acid
terferon response factor 7; RIG-
entiation-associated protein 5;
e Research Institute, National
sda, MD 20892, USA.
.have played an important role in the elucidation of many critical bio-
chemical pathways. Examples of these small molecule diseases include
organic acidemias (OA), urea cycle disorders (UCD), primarymitochon-
drial disorders (pMD), and fatty acid oxidation disorders (FAOD). The
untreated clinical course for most of these diseases ranges from mental
retardation to coma and death, reinforcing the need for lifelongmedical
management [2–5]. This ongoing patient care requires judicious moni-
toring of growth and developmental parameters, as well as nutritional
and biochemical status [2,6,7].
Despite close monitoring of metabolic and nutritional status, pa-
tients with IEM may experience a functional deterioration known as
metabolic decompensation [8–10]. These periodic episodes are poten-
tially life threatening, display high rates ofmorbidity [11], and can result
in long-term sequelae [12]. Duringmetabolic decompensation, disease-
speciﬁc biochemical perturbations occur and include acidosis (e.g. OA,
pMD), hyperammonemia (e.g. UCD) and hypoglycemia (e.g. FAOD).
Common precipitants include fasting and infection, predominantly,
respiratory viral infection. In a cohort of patients with UCD, we
previously reported that infection was themost common cause of met-
abolic decompensation (i.e. hyperammonemia) and was associated
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tants [11]. Based on these clinical data, we constructed a model system
ofmetabolic decompensation due to inﬂuenza infection in spf-ash[13], a
mouse model of ornithine transcarbamylase deﬁciency, the most com-
mon urea cycle disorder. Inﬂuenza infection in spf-ash resulted in a fur-
ther disruption of urea cycle function. Interestingly, despite having no
visible pathologic changes by histology, wild-type (WT) animals also
had reduced mitochondrial urea cycle enzyme activities and hepatic
urea cycle intermediates arginine and aspartate.
The liver is a critical organ inmany IEM.Many of the life-threatening
biochemical perturbations seen on clinical testing during metabolic de-
compensation (i.e. hyperammonemia, acidosis, hypoglycemia) can be
traced to impaired intermediary metabolism in the liver, prompting us
to reconsider this biochemical instability as hepatic metabolic decom-
pensation. Since WT mice underwent hepatic metabolic adaptations in
nitrogen metabolism during inﬂuenza infection, we hypothesized that
hepatic metabolic decompensation due to infection involves aspects of
normal hepatic physiology, to which, IEM are unable to adapt. To ex-
pand the phenotype of hepaticmetabolic adaptations seen during infec-
tion, we carried out untargetedmetabolic proﬁling of livers using a dual
mass spectrometry platform in C57Bl/6 mice infected with PR8 inﬂuen-
za. These studies, combined with cellular immunology investigations,
suggest that the innate immune system in the liver, particularly Kupffer
cells, plays an important role in the modulation of hepatic metabolism
during inﬂuenza infection and participates in hepatic metabolic decom-
pensation in IEM.
2. Materials and methods
2.1. Infection with A/PR/8/34 (PR8)
The experiments outlinedwere performed on B6 (C57Bl/6, The Jack-
son Laboratory, Bar Harbor, ME)mice. Micewere housed in a pathogen-
free facility, caged individually, had access to a 24% protein mush-based
feed, Nutragel (Bio-Serv, Frenchtown, NJ), and autoclaved in reverse os-
mosiswater. Micewere kept in a temperature (22+2 °C) andhumidity
(30–70%) controlled environment with a 12-hour light cycle. Mouse
adapted human inﬂuenza virus A/PR/8/34 (PR8) for infection was pro-
duced as described previously [14]. Eight-week-old mice were exposed
to an infective dose of PR8 (500 TCID50) in an aerosolization chamber
(Glas-Col, Terre Haute, IN) [15]. Uninfected control mice were matched
for food intake. Mice were sacriﬁced on Day 5 of infection by 5%
Isoﬂurane inhalation with cervical dislocation. All tissues were isolated
and stored at−80 °C until use. Single dose liposomal clodronate (200
μL/animal i.p., Encapsula NanoSciences LLC, Brentwood, TN) was used
to deplete Kupffer cells. All animal care and procedures were carried
out according to the criteria outlined in the “Guide for the Care and
Use of Laboratory Animals” prepared by the National Academy of Sci-
ences and published by the National Institutes of Health (NIH publica-
tion 86–23 revised 1985) and were authorized by the Animal Care and
Use Committees of the National Human Genome Research Institute.
2.2. Viral titers
Viral titers in lungs and liver were determined using published assay
based on the infection of MDCK cells [16]. The inverse of the dilution at
which 50% of the wells showed cytopathic effect was recorded as the
50% tissue culture infectious dose (TCID50).
2.3. Kupffer cell isolation and stimulation
Kupffer cell isolation was performed as previously published [17].
Brieﬂy, liver was dissected and incubated at 37 °C with collagenase for
30 min. Digested tissue was passed through a mesh ﬁlter, resuspended
in 33%percoll and centrifuged at 500×g for 20min. Redblood cellswere
lysed, and cells were washed and plated at 3 × 106 cell/mL. Adherentcells were stimulated with 1 μg/mL LPS (Sigma Aldrich, St. Louis, MO)
for 24 h. Cytokines were analyzed using a Cytometric Bead Array for
mouse inﬂammatory markers on a FACSCalibur ﬂow cytometer accord-
ing to the manufacturer instructions (BD Biosciences, San Jose, CA).
2.4. Biochemical parameters
Glucose testing was performed on retro-orbital collected whole
blood using standard handheld glucometer (AccuCheck, Roche Diag-
nostics, Indianapolis, Indiana). Serum aspartate aminotransferase and
alanine aminotransferase were determined via dry-slide technology
(VetTest 8008, IDEXX, Columbia, MO).
2.5. Histology
All histologic procedures were performed by an outside vendor
(Histoserv, Germantown, MD) and included hematoxylin, eosin, and
oil red o staining. Antibody for 3-nitrotyrosine was used for IHC
nitrosylation studies (Cayman Chemical, Ann Arbor, MI) and was per-
formed according to a standard protocol (http://www.abcam.com/tag/
ihc%20protocols).
2.6. Electron microscopy
Mouse livers (1 mm3) were ﬁxed overnight at 4 °C in 2% glutaralde-
hyde in 0.1 M cacodylate buffer (pH 7.4) and washed with cacodylate
buffer three times. The tissues were ﬁxed with 2% OsO4 for two hours,
washed again with 0.1 M cacodylate buffer three times, and washed
with water and placed in 1% uranyl acetate for one hour. The tissues
were subsequently serially dehydrated in ethanol and propylene oxide
and embedded in EMBed 812 resin (Electron Microscopy Sciences,
Hatﬁeld, PA, USA). Thin sections, approx. 80 nm, were obtained by uti-
lizing the Leica ultracut-UCT ultramicrotome (Leica, Deerﬁeld, IL, USA)
and placed onto 300mesh copper grids and stained with saturated ura-
nyl acetate in 50% methanol and then with lead citrate. The grids were
viewed in the JEM-1200EXII electron microscope (JEOL Ltd, Tokyo,
Japan) at 80 kV and images were recorded on the XR611M, mid
mounted, 10.5 Mpixel, CCD camera (Advanced Microscopy Techniques
Corp, Danvers, MA, USA).
2.7. Metabolomics
Sample processing and metabolite identiﬁcation with relative
quantitation were done by Metabolon (Research Triangle Park, NC)
using proprietary methods on GC/MS and LC/MS/MS platforms
[18]. Raw data is provided in Supplemental Table 1. Acylcarnitine
proﬁles on tissue homogenates were performed Biochemical
Genetics and Metabolism Laboratory, Children's National Medical
Center (Washington, DC).
2.8. mRNA expression proﬁling and qRT-PCR
RNA was extracted from homogenized liver tissue using a kit
(Qiagen, Germantown, MD). For RT-PCR, 1 μg of RNA was reverse tran-
scribed to cDNA using a modiﬁed MMLV-reverse transcriptase (iScript,
Bio-Rad, Hercules, CA). Real-time quantitative PCR reactions were car-
ried using TaqMan commercial primers (Applied Biosciences, Carlsbad,
CA). All results were normalized to β-actin. Reactions were cycled and
quantitated with an ABI 7500 Fast Real Time PCR System (Applied
Biosystems, Foster City, CA).
2.9. Immunoblot
For western blot analysis, 30 μg of proteinwas loaded on 4–20% Tris-
glycine polyacrylamide gels. The gels were transferred to poly-
vinylidene diﬂuoride membrane using the iBlot Dry Blotting System
Table 1
Acylcarnitine proﬁle of livers during infection with PR8 inﬂuenza. Acylcarnitine proﬁles
were performed in liver homogenates normalized for protein content. Metabolite values
were converted to Z-scores and represented a heatmap based on their relative concentra-
tions. *P b 0.05.
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and probed with primary antibodies according to the manufacturers
suggested dilutions: VLCAD, LCAD, HADHA (Abcam, Cambridge, MA),
and β-actin (Sigma-Aldrich, St. Louis, MO). Incubation was done with
appropriate secondary antibodies. Image analyses were performed
using an Odyssey Imager (LiCor, Lincoln, NE).2.10. Flow cytometry
Antibodies were purchased from BD Biosciences (San Jose, CA). Data
were acquired on a FACSCalibur ﬂow cytometer (BD Biosciences) and
analyzed using FlowJo software (Tree Star, Ashland, OR). Hepatic im-
mune cells were isolated by collagenase digestion of the liver as
outlined above.2.11. β-oxidation of palmitate
Palmitate oxidation was performed on Hep3B cells measuring oxy-
gen consumption rates using a Seahorse XF24 Analyzer (Seahorse Bio-
science, North Billerica, MA). Brieﬂy, Hep3B cells (30,000/well) were
incubated overnight with TNFα (100U/mL). Oxygen consumption
rates were determined while using the XF Cell Mito Stress kit and XF
Palmitate-BSA FAO Substrate (Seahorse Bioscience, North Billerica,
MA) according to the manufacturer instructions.2.12. Data analysis and statistics
Summary statistics were calculated for all data. Two-sided student's
t-test, Mann–Whitney t-test, Welch's t-test and survival analysis was
usedwhen appropriate. P-values less than 0.05were considered to indi-
cate statistical signiﬁcance. Baseline statistical analyseswere performed
using Prism5 (GraphPad Software, Ja Jolla, CA) software package. A con-
servative approach was adopted to analyze Affymetrix gene arrays and
metabolomics in order to minimize false positives. All analyses were
performed using R v3.1.0 (http://www.R-project.org/.), Bioconductor
v3.0, and oneChannelGUI v1.32 [19]. Quality control was performed by
inspecting image representations of themicroarrays for obvious defects
and principal component analysis performed to verify reproducibility
among replicates. Quantile normalization and RMA summarization
were performed using an IQR ﬁlter of 0.25 to ﬁlter probesets that did
not change signiﬁcantly among samples. RankProduct with 500 permu-
tations and limmawere applied to obtain differentially expressed genes.
Differentially expressed genes or metabolites were then selected as
those signiﬁcantly differentially expressed (Benjamini–Hochberg
FDR b 0.05) for bothmethods andwith fold change N 0.5. GO term anal-
ysis and networks were computed using ClueGO [20]. Plots were creat-
ed using ggplot2 (http://ggplot2.org) and the directlables package
(http://directlabels.r-forge.r-project.org/).
3. Results
3.1. Infection with PR8 inﬂuenza results in hepatitis in mice
Respiratory viral illness is a common cause of metabolic decompen-
sation [11]. To study the effects of respiratory viral infection on the liver,
we employed a model system previously published by our laboratory
using the mouse-adapted inﬂuenza A/PR/8 (PR8) virus [13]. WT mice
were infected on Day 0 with 500 TCID50 using an infection aerosoliza-
tion apparatus and euthanized on Day 5 (Fig. 1A and B). To control for
nutritional confounders, infected and control animals were matched
for food intake (pair-fed) and were euthanized on Day 5 (Fig. 1B). Tis-
sues were then collected, snap-frozen and stored at−80 °C until anal-
ysis. Mice challenged with PR8 displayed signs of infection including
reduced oral intake, rufﬂed fur and decreased social and grooming be-
haviors beginning atDay 2–3 (Fig. 1B, gray shading), consistentwith cy-
tokine release [15]. In the lungs of infected animals, increased viral load
was detected by qRT-PCR for non-structural protein (NS1) and by
MDCK cell dilutions of viral titers (Fig. 1C). Weight loss was similar on
day 5, regardless of the experimental condition (Fig. 1D) suggesting
that the animals were well matched for intake. Alongwith these indica-
tors of infection, signiﬁcant increases in serum AST (2X, P b 0.01) and
ALT (3X, P b 0.05) were seen, indicating hepatitis (Fig. 1E). Along with
this hepatitis, animals infected with PR8 inﬂuenza also dropped their
blood glucose by approximately 30 μg/dL compared to pair-fed controls
(Fig. 1F, P b 0.01) consistent with increased glucose utilization during
infection.
3.2. Liver metabolomics during PR8 infection show changes in fatty acids
During PR8 infection, the observed depression in blood glucose im-
plied impaired metabolic homeostasis. Blood glucose is maintained
through replenishing and sparing processes, gluconeogenesis and fatty
acid oxidation, respectively. In order to characterize alterations in bio-
chemical pathways that may impact metabolic homeostasis in infected
mice, we conducted untargeted metabolomic studies in livers isolated
from infected and pair-fed WT mice (Fig. 2). Using a dual platform of
gas chromatography mass spectrometry and liquid chromatography
tandem mass spectrometry, 334 metabolites were measured compris-
ing lipids, amino acids, dipeptides, cofactors, vitamins, and nucleotides
(Supplemental Table 1). Approximately 81 metabolites were identiﬁed
as signiﬁcantly changed (P b 0.05) in infected mice. To characterize the
Fig. 1. PR8 inﬂuenza infection in WT mice produces hepatitis. Mice infected with mouse adapted PR8 inﬂuenza were euthanized at Day 5 and tissues were harvested. (A) Inhalation in-
fection apparatus (N= 10/group). (B) Study protocol. Shaded areas indicate appearance of sickness behaviors. Uninfectedmicewere matched for food intake (pair-fed) (C) Viral titers in
lungs on Day 5 (N = 5–6 / group). qRT-PCR for inﬂuenza PR8 NS1 (left) and lung viral titers (right). (D) Weights for PR8 infection and pair-fed conditions. (F) Blood glucose. PR8 =
inﬂuenza A/PR/8. Hatched bars indicated statistical signiﬁcance. * b 0.05. ** b 0.01.
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superpathways and 64 subpathways. At the superpathway level
(Fig. 2A), signiﬁcant distinctions could not bemade during infection, al-
though in general, lipids exhibited decreased Log2 mean fold changes
and a wider distribution of values compared to other categories. At
the subpathway level (Fig. 2B), ﬁner distinctions between infected and
pair-fed animals could be made. Lipids (pink boxplots) were noted as
some of the most signiﬁcantly impacted metabolites in this study. Bile
acids were depressed, indicating decreased synthesis and liver dysfunc-
tion. Essential fatty acyl and long chain acyl CoA species were also re-
duced, along with several metabolites involved in CoA synthesis
(Supplemental Table 2). Focusing on long chain fatty acids (Fig. 2C),
arachidonate was elevated, consistent with inﬂammation, while C16–
C22 long chain fatty acids were reduced. This depression in acyl CoA
species also translated into a depression in long chain acylcarnitines,
particularly C14, C16 and C18 chains (P b 0.05, Table 1). The relative re-
ductions of fatty acid acyl CoA and carnitine esters in infected micealluded to hepatic adaptations in mitochondrial β-oxidation of long
chain fatty acids during infection.
3.3. PR8 infection is associated with a depression in components of long
chain β-oxidation
Since infected animals had a metabolomic signature consistent with
alterations in long chain fatty acids, we next examined the components
of hepatic β-oxidation. Pair-fed and infected mice were euthanized at
5 days, and livers were harvested and snap frozen until use. During in-
fection, multiple steps in the β-oxidation of long chain fatty acids
were disrupted at the mRNA level (P b 0.05, Fig. 3A) including the car-
nitine cycle (carnitine palmitoyl transferase 2 (Cpt2), carnitine
acylcarnitine translocase (Cact)), fatty acid dehydrogenases (very long
chain acyl CoAdehydrogenase (Acadvl), long chain acyl CoA dehydroge-
nase (Acadl), long chain hydroxyacyl CoA dehydrogenase (Hadha) and
the ﬁnal common pathway responsible for feeding electrons to the
Fig. 2.Metabolic adaptations in the liver during PR8 inﬂuenza infection. Livers were harvested from infected and pair-fed mice. Liver homogenates were normalized for protein content
and analyzed using GC–MS and LC–MS/MS platforms. (A) Boxplots of Log2 fold changes for metabolic superpathways. Pink— lipids, Orange— vitamins and cofactors, Blue— xenobiotics,
Yellow— peptides, Green— carbohydrates, L. blue— amino acids, L. orange— nucleotides, Gray— energymetabolites. (B) Boxplots of Log2 fold changes formetabolic subpathways. Color
coding from (A) superpathways applies. Size of the bubble on the right axis represents number of metabolites for each subpathway. (C) Log2 fold changes for long chain fatty acids.
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pression in fatty acid oxidation transcripts coincided with decreased
PparαmRNA (P b 0.01), a positive regulator of β-oxidation mRNA ex-
pression (Fig. 3B). Increased FasnmRNA (P b 0.05) suggested that the
liver had switched from β-oxidation to fatty acid synthesis (Fig. 3C).
The perturbations in β-oxidation were also seen on the protein level
(Fig. 3D). VLCAD, LCAD and HADHA were reduced by N50% (P b 0.05).
Overall, the mRNA and protein results, along with the reduction in
blood glucose, suggest a mild depression of long chain β-oxidation dur-
ing inﬂuenza infection in mice.
3.4. The hepatic transcriptional signature shows an antiviral response to
inﬂuenza
In order to identify master regulators responsible for the metabolic
changes seen, we performed transcriptional proﬁling of infected and
pair-fed livers. Starting with stringent criteria (Fig. 4A, P b 10−7), infec-
tion yielded 35differentially upregulated genes (Supplemental Table 3).
Not surprisingly, someof the highest values seenwere related to the he-
patic acute phase response: serum amyloid A1 (Saa1) and lipocalin 2
(Lcn2), which were conﬁrmed by qRT-PCR (Fig. 4B). In addition to the
acute phase response, increased interferon response factor 7 (Irf7) was
also observed suggestive of anti-viral innate immunity (Fig. 5A–B).
Gene ontology analysis (Fig. 4C, Log2 N 1.5X, P b 0.01) conﬁrmed that
the innate immune response was activated in the liver. Several innate
immune pathways were involved in the anti-viral response and includ-
ed pattern recognition receptor signaling (toll like receptors, (TLRs)),viral nucleic acid sensing (RIG-I, MDA5) and interferon signaling (type
I interferons). These results provide evidence for hepatic innate immune
activation during PR8 inﬂuenza infection.
3.5. Innate immune activation in the liver with PR8 infection
As a result of the signiﬁcant transcriptional signature suggesting he-
patic sensing of inﬂuenza, we hypothesized that there were signiﬁcant
changes in hepatic immune cell populations. The liver is a highly immu-
nologic organ with immune cells constituting 15% or more of the total
cell count [21,22]. To examine the changes in speciﬁc cell populations
in the liver, we analyzed collagenase digested liver samples using ﬂow
cytometry. Cells of the adaptive immune system, T-cells and B-cells,
showed little change with inﬂuenza infection (data not shown). In con-
trast, there were signiﬁcant changes in innate immune cells. Inﬂamma-
tory myeloid cells (Gr-1+ CD11b+) increased 3× or more, and tissue
resident macrophages (F4/80+ CD11b+), known as Kupffer cells, in-
creased approximately 2× with infection (Fig. 5A). Also of note, the in-
vading inﬂammatory myeloid cells (Gr-1+ CD11b+) were primed to
induce tissue damage with increased FasL on their surface (Fig. 5A,
upper bar graph).
Kupffer cells play a central role in host defense as well as liver dis-
ease [23]. With increased numbers of Kupffer cells in the liver, we pro-
ﬁled their cytokine response in vitro. Supernatant from Kupffer cells
from infected animals showed secretion of hepatotoxic inﬂammatory
cytokines (IL-6 and TNFα) at baseline (Fig. 5B). Evaluation of the full ac-
tivation potential of Kupffer cells using LPS resulted in enhanced
Fig. 3. Fatty acid oxidation mRNA and protein is decreased during PR8 inﬂuenza infection. mRNA was extracted from infected and pair-fed livers and qRT-PCR was performed. (A) mRNA ex-
pression for components of the fatty acid oxidation pathway, Cpt2— carnitine palmitoyl transferase 2, Cact— carnitine acylcarnitine translocase, Acadvl— very long chain acyl CoA dehydroge-
nase, Acadl— long chain acyl CoA dehydrogenase,Hadha— hydroxy acyl CoA dehydrogenase, Etfa— electron transport ﬂavoprotein. (B) PparαmRNA expression in livers, Pparα— peroxisome
proliferator activated receptor alpha. (C) FasnmRNA expression in livers, Fasn— fatty acid synthase. (D) Fatty acid oxidation proteins by immunoblot. * P b 0.05, ** P b 0.01, *** P b 0.001.
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10. In order to assess the effects of the inﬂammatory cytokines produced
by Kupffer cells onmitochondrial long chain β-oxidation, a liver cell line
(Hep3B) was incubated with the prototypical inﬂammatory cytokine,
TNFα. Following incubation with TNFα for 24 h (Fig. 5C), the basal
(P b 0.01) andmaximal (P b 0.01) oxidation of palmitate was depressed
demonstrating impaired ﬂux through the long chain β-oxidation path-
way. Similar to our ﬁndings in the mouse livers during infection,
PparαmRNA was also decreased in Hep3B (Fig. 5D).
Despite this robust hepatic immune response, the liver was free of
replicating virus (data not shown) andhistologywas essentially normal.
Hematoxylin and eosin stains (Supplemental Fig. 1A) failed to show any
gross abnormalities such as profound inﬁltrates or necrosis. Although
small amounts of scattered microvesicular steatosis (Supplemental
Fig. 1B) were barely visible, this ﬁnding was not consistent. Mitochon-
drial number and morphology (Supplemental Fig. 1C) were also noted
to be normal by electronmicroscopy. However, with this normal histol-
ogy, signiﬁcant tyrosine nitration (3-nitrotyrosine) was located aroundthe hepatic vessels as well as the parenchyma by immunohistochemis-
try (Supplemental Fig. 2) suggestive of inducible and endothelial nitric
oxide synthase activation (NOS) via inﬂammatory cytokines [24,25].
3.6. Depletion of Kupffer cells modulates hepatic β-oxidation mRNA
Kupffer cells were increased in the liver during PR8 inﬂuenza infec-
tion and secreted inﬂammatory cytokines that inhibit fatty acid oxida-
tion in vitro. In order to characterize the role of Kupffer cells in the
modulation of hepatic long chain β-oxidation, we employed an
immunomodulation strategy. Clodronate liposomes were given at Day
3 of infection,which corresponds to the appearance of illness, to deplete
Kupffer cells [26]. Administration of clodronate liposomes resulted in
successful depletion of Kupffer cells (Fig. 6A) as determined by ﬂow cy-
tometry. Following this treatment, there was a recovery of Cpt2, Acadvl,
Acadl, Hadha, and EtfamRNAs during infection (P b 0.05, Fig. 6B, upper
and lower panels). VLCAD protein also increased, as measured by im-
munoblot (P b 0.05), while LCAD and HADHA remained unchanged
Fig. 4. Transcriptional signature is consistent with an innate immune response in the liver. mRNAwas extracted from infected and pair-fed livers andmRNA expression analysis and qRT-
PCR was performed. (A) Log10 P-value of differentially expressed genes. (B) qRT-PCR conﬁrmation of top three mRNA targets. (C) Transcriptional proﬁle and gene ontology analysis of
hepatic response. Circle size indicates number of genes with N1.5x increase and P b 0.01.
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of multiple mRNAs for β-oxidation, Pparα mRNA (P b 0.05) also in-
creased (Fig. 6C). Despite this improvement in β-oxidation mRNA and
VLCAD protein, blood glucose dropped even further (P b 0.001,
Fig. 6D). This further drop in blood glucose provides evidence for in-
creasedwhole body glycolysis that cannot be compensated due to an in-
complete recovery of long chain β-oxidation.
4. Discussion
Patients with IEM are at risk for developing metabolic decompensa-
tion during infectious illnesses.Many of the biochemical ﬁndings during
metabolic decompensation can be traced directly to impaired interme-
diary metabolism in the liver [27]. As previously published by our
group, WT mice exhibit inhibition of mitochondrial enzymes of the
urea cycle with perturbations in urea cycle intermediates during inﬂu-
enza infection [13]. Our current study expands on this hepatic biochem-
ical phenotype to include β-oxidation of long chain fatty acids. More
importantly, we also identify a critical pathophysiologic process that
may be a common thread in hepatic metabolic decompensation in
IEM, that is, the activation of the innate immune system in the liver.
Fatty acid oxidation (FAO), also known as β-oxidation, occurs in the
mitochondria of most tissues and involves the concerted effort of over
20 different enzymes [28]. This essential metabolic pathway provides
the majority of energy required for daily functioning of the liver [29].
The ﬁrst step in β-oxidation involves the transport of long chain fatty
acids into the mitochondrial matrix via the carnitine shuttle, whereas
medium and short chain fatty acids readily cross the mitochondrial
membrane. Once in the mitochondrial matrix, acyl CoA dehydroge-
nases, displaying chain-length speciﬁcity, catalyze the breakdown of
fatty acids [28]. By way of each turn of the β-oxidation cycle, acetyl
CoA and NADH and FADH2 are produced. Acetyl CoA enters the tricar-
boxylic acid cycle, and NADH and FADH2 are fed to the electron trans-
port chain driving ATP generation. During illness, glucose and fattyacids have an intimate relationship. β-oxidation of fatty acids plays a
critical role in providing glucose-sparing metabolic reserve. The Randle
cycle or glucose–fatty acid cycle, demonstrates this important concept:
due to a deﬁciency in energy generation from fatty acids and ketones,
glucose will be consumed [30].
In the studies presented herein, 3 days of clinical infection with
PR8 inﬂuenza leads to a physiologic adaptation that includes a
depression of β-oxidation intermediates: coenzyme A, long chain
acyl-CoA and carnitine species, and acetyl-carnitine (Fig. 2,
Table 1). Due to the nature of the experimental design, the direction
of these metabolites (i.e. production versus consumption) cannot be
imparted from the data. However, given that multiple components of
the long chain β-oxidation pathway were also decreased at the level
of mRNA and protein (Fig. 3), we can infer its compromise. This
statement is further supported by the drop in blood glucose
(Fig. 1F), suggesting that the glucose-sparing effect of long chain β-
oxidation is insufﬁcient during inﬂuenza infection.
A signiﬁcant question that arises from our studies concerns the
physiologic signiﬁcance of a depression in β-oxidation during infection.
The mild depression in fatty acid oxidation seen during inﬂuenza infec-
tion may reﬂect limited hepatic metabolic ﬂexibility due to energetic
constraints [31–33]. Infection in general is an energetically costly pro-
cess. Basal metabolic rate during infection increases by N13% for each
1 °C, and can even approach 10,000 cal daily during sepsis [34,35].
This hypermetabolic state places increased demands on metabolic re-
sources and requires increased intake, which oftentimes cannot be
met, as it occurs at a time when caloric intake is curtailed as a result of
illness [35]. This systemic energy deﬁciency may also be compounded
by limitations in liver bioenergetics. Unlike the heart, which has
a N10-fold dynamic range of ATP production, the liver has a dynamic
range of ATP production that is just 2-fold [36]. Given this limited
range of energetic ﬂexibility, it is reasonable to conceive that the liver
would prioritize certain cellular processes such as protein synthesis
for the acute phase response versus intermediary metabolism: bile
Fig. 5. Innate immune activation in the liver during PR8 inﬂuenza infection. Collagenase digested livers were examined for immune cell populations. (A) Increased inﬂammatory myeloid
cells (Gr-1+ CD11b+) and Kupffer cells (F4/80+ CD11b+) by ﬂow cytometry. Representative ﬂow cytometry (left ﬁgure). FasL (CD178+) MFI on inﬂammatory macrophages and Kupffer
cells (right ﬁgure). Experiments were repeated three ormore times. (B) Cytokine production by adherent Kupffer cells, Il-6— interleukin 6, Il-10— interleukin 10, TNFα— tumor necrosis
factor alpha. (C) Basal andmaximal palmitate oxidation inHep3B cells exposed to 24h of TNFα. *P b 0.05, **P b 0.01, ***P b 0.001, ****P b 0.0001. All experimentswere performed3 ormore
times.
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lism [13]. This reprogramming of liver metabolism may be mediated
through the repression of PPARα (Fig. 3B), a known positive regulator
of β-oxidation.
The current data on the hepatic metabolic response to infection has
been reported in various sepsis models and vary according to the stage
of sepsis, dosing and the pathogen involved. The early stress response to
sepsis is marked by hyperglycemia resulting from the release of neuro-
endocrine hormones and increased hepatic gluconeogenesis [37]. In ad-
dition, fatty acid oxidation is also increased in the early stages of sepsis,
also providing a glucose-sparing effect [38–40]. Our ﬁndings are in
keeping with the data reported in the later stages of sepsis, which
shows a depression of hepatic metabolic function. In a study of
endotoxemic rats, the rate of hepatic CPT1a-dependent palmitate oxida-
tion and ketogenesis were reduced at 24 h[41]. This reduction in β-
oxidation may be partially due to limited substrates. During pneumo-
coccal sepsis with caloric deprivation, rats displayed reduced ketogene-
sis in the liver secondary to an insufﬁcient supply of fatty acids [42]. Our
data are consistent with these ﬁndings; livers of mice infectedwith PR8
inﬂuenza showed a reduction in fatty acyl CoA and carnitine esters(Fig. 2, Supplemental Table 2, Table 1). In addition to the data similari-
ties, our study designwas also similar with respect to caloric restriction,
and implies a complex interaction between infection and food restric-
tion that is distinct from the physiology of uninfected pair-fed animals.
The systemic immune response to PR8 infection in B6 mice is well
documented, particularly with regard to serum cytokine release. Begin-
ningwith the peak of lung viral titers at 48 h, there is a signiﬁcant rise in
chemokines (KC, CCL2, RANTES), proinﬂammatory cytokines (IL-1β, IL-
6, TNFα), and interferons (IFNβ), all of which continue to rise up to
120 h post infection [15]. In addition to this systemic rise in inﬂamma-
tory mediators, WTmice displayed a signiﬁcant hepatic innate immune
response, much to our surprise due to the location of the primary infec-
tion. Gene ontology of expression proﬁling of livers displayed a marked
innate immune response signature with up-regulation of toll-like re-
ceptor and viral sensing pathways (Fig. 4C). This was seen in conjunc-
tion with a hepatic increase in inﬂammatory myeloid and Kupffer cell
populations (Fig. 5A). Similar hepatic innate immune activation is also
seen during other non-hepatic systemic infections: sinusoidal dilatation
combined with an inﬂux of inﬂammatory cells, primarily Kupffer cells
[43].
Fig. 6. Liposomal clodronate treatment restores expression of fatty acid oxidation mRNA. Animals infected with inﬂuenza A were injected with a single dose of liposomal clodronate to
deplete Kupffer cells. (A) Flow cytometry conﬁrms depletion of Kupffer cells. (B) mRNA expression for components of the fatty acid oxidation pathway. (C) PparαmRNA expression.
(D) Blood glucose during treatment with liposomal clodronate. *P b 0.05, **P b 0.01, *** P b 0.001, ****P b 0.0001. All experiments were performed 3 or more times.
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ance of blood pathogens, these functions overlap with other tissues in-
volved in immunosurveillance, particularly the liver.With its dual blood
supply from the hepatic artery and portal vein, the liver receives 30% of
the total blood volume per minute [44], making it an ideal organ for
immunosurveillance. As the largest organ in the body, the liver contains
the largest population of resident macrophages, Kupffer cells. Kupffer
cells account for up to 35% of non-parenchmyal cells in the liver and
80–90% of all tissue macrophages in the body [45]. This heterogeneous
population consists of large periportal and smaller mid-zonal/
perivenous Kupffer cells. As a result of being exposed to incoming mo-
lecular signals due to their location in the periportal zone and sinusoids,
Kupffer cells exhibit phagocytosis, lysosomal protease activity, and cy-
tokine output [23]. Depletion of Kupffer cells by liposomal clodronate
during Listeria monocytogenes and Borrelia burgdorferi infections results
in increased lethality, demonstrating their key role in immunity to
blood born pathogens [46,47].
Besides systemic immunity, Kupffer cells also play a role in hepatic
injury. Hepatocytes adjacent to the sinusoids may undergo damage
and apoptosis due to activation of Kupffer cells, a bystander effect
[48]. This local tissue innate immune reaction is likely responsible for
the increase in AST and ALT (Fig. 1) seen during inﬂuenza infection in
mice and humans [49]. Although inﬂuenza virus could not be isolated
from the liver in our model, this does not exclude the possibility of pe-
riodic viremia activating Kupffer cells. This hypothesis is further sup-
ported by the innate anti-viral signature seen in the liver (Fig. 4C).
Our proposed pathophysiologic mechanism of bystander hepatocyte
damage is also reinforced by depletion studies. The role of Kupffer
cells in inﬂammatory hepatotoxicity has been demonstrated in several
other experimental systems using liposomal clodronate: concanavalin,
alcohol, and acetaminophen induced hepatic damage and non-
alcoholic fatty liver disease [50]. In our model, depletion of Kupffer
cells by liposomal clodronate led to an improvement in components
of β-oxidation mRNA and some proteins (Fig. 6B, Supplemental Fig. 3)
demonstrating their role in the modulation of fatty acid metabolism.
However, the lack of a full recovery with liposomal clodronate treat-
ment implies that the nutritional management of hepatic metabolic
decompensation with intravenous glucose still plays a critical role.
Moreover, the further depression in blood glucose due to Kupffer cell
depletion suggests that the relationship between these tissuemacrophages and liver metabolism is more complex and under recog-
nized, prompting the need for additional investigation.
Although Kupffer cell hepatotoxicity may be mediated in several
ways, cells isolated from infected mice produced increased IL-6, IL-10
and TNFα in our model system (Fig. 5B). These cytokines likely play a
part in the hepatitis seen (Fig. 1E). In another experimental system of
infection, TNFα, produced by Kupffer cells and inﬂammatory mono-
cytes, is a critical mediator in immune mediated liver damage during
Entamoeba histolytica infection [51]. Although we did not see an in-
crease in apoptosis in the livers of infected animals, TNFα was likely
an important mediator in the inhibition of β-oxidation (Fig. 5C) acting
via the repression of PPARα (Fig. 5D and [52]).
The mechanisms by which proinﬂammatory cytokines inhibit long
chain β-oxidation likely involve multiple signaling pathways, including
excess nitric oxide and related free radicals [53]. S-nitrosylation or tyro-
sine nitration ofmetabolic enzymesmay alter theirmetabolic activity or
increase their turnover. Indeed, the livers from our infected mice
showed increased periportal and parenchymal tyrosine nitration, con-
sistent with inﬂammatory cytokine exposure (Supplemental Fig. 2). In
keeping with our ﬁndings, previous reports have also found that TNFα
alone or in combination with IL-1 or IL-6, results in decreased hepatic
fatty acid oxidation, ketone body production and acetyl CoA/CoA ratios
in vitro and in vivo [54–56]. Interestingly, these same cytokines are re-
sponsible for the synthesis of hepatic acute phase proteins [57] suggest-
ing that they may be an important regulator of the re-prioritization of
metabolism in hepatocytes during infection. As a result, we propose
that further studies targeting inﬂammatory cytokines like TNFα are
necessary and may lead to potential therapeutic targets during hepatic
metabolic decompensation.
5. Conclusions
In conclusion, ourwork has expanded thephenotype of hepaticmet-
abolic adaptations to inﬂuenza infection. InWTmice, inﬂuenza infection
with PR8 inﬂuenza leads to a decrease in intermediates and enzymes in-
volved in hepatic β-oxidation, an important regulator of metabolic re-
serve. More importantly, our study is the ﬁrst to suggest that the role
of the liver as an immunologic organ is central in the pathophysiology
of hepatic metabolic decompensation in IEM due to viral infection. The
dual function of the liver as amajormetabolic regulator and a secondary
2400 T.N. Tarasenko et al. / Biochimica et Biophysica Acta 1852 (2015) 2391–2401lymphoid organ responsible for immunosurveillance places this organ
at risk for signiﬁcant hepatotoxicity. This normal physiologic function
is predicted to be deleterious in IEM. Based on this assertion, strategies
aimed at modulating the hepatic innate immune response may be a vi-
able target for intervention in the treatment of hepatic metabolic
decompensation.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2015.08.021.
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